12:13 AM EDT, 07/17/2026 (MT Newswires) -- Dassault Systèmes (DSY.PA) is in discussions to acquire drug trial software company ArisGlobal at a valuation of $2 billion, London's Financial Times reported Thursday, citing people familiar with the matter. The French software company's talks with Swedish buyout group Nordic Capital for the potential acquisition could still fail, the report noted. Dassault Systèmes and Nordic Capital did not immediately respond to MT Newswires' requests for comment. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.